494 related articles for article (PubMed ID: 23667969)
21. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Ghislain PD; Roujeau JC
Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
[TBL] [Abstract][Full Text] [Related]
22. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
[TBL] [Abstract][Full Text] [Related]
23. Making a diagnosis in severe cutaneous drug hypersensitivity reactions.
Ardern-Jones MR; Mockenhaupt M
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):283-293. PubMed ID: 31247634
[TBL] [Abstract][Full Text] [Related]
24. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
25. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
26. Immunological aspects of nonimmediate reactions to beta-lactam antibiotics.
Rodilla EM; González ID; Yges EL; Bellido FJ; Bara MT; Toledano FL
Expert Rev Clin Immunol; 2010 Sep; 6(5):789-800. PubMed ID: 20828287
[TBL] [Abstract][Full Text] [Related]
27. [Drug reaction with eosinophilia and systemic symptoms].
Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic approach to drug allergy.
Harr T
Chem Immunol Allergy; 2012; 97():47-60. PubMed ID: 22613853
[TBL] [Abstract][Full Text] [Related]
29. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
Worswick S; Cotliar J
Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
[TBL] [Abstract][Full Text] [Related]
30. Treatments for Severe Cutaneous Adverse Reactions.
Cho YT; Chu CY
J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
[TBL] [Abstract][Full Text] [Related]
31. [Cutaneous reactions to drugs].
Mulder WM; Meinardi MM; Bruynzeel DP
Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
[TBL] [Abstract][Full Text] [Related]
32. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous side effects due to psychiatric drugs].
Rebok F; Pérez Roldán ML; Daray FM
Vertex; 2008; 19(82):348-56. PubMed ID: 19424517
[TBL] [Abstract][Full Text] [Related]
34. Stevens-Johnson syndrome: report on a case with a strange complaint of allergy to bus.
Mohammadzadeh I; Khaledi M; Rezaei N
Acta Clin Croat; 2013 Sep; 52(3):391-4. PubMed ID: 24558775
[TBL] [Abstract][Full Text] [Related]
35. Phenotype standardization for immune-mediated drug-induced skin injury.
Pirmohamed M; Friedmann PS; Molokhia M; Loke YK; Smith C; Phillips E; La Grenade L; Carleton B; Papaluca-Amati M; Demoly P; Shear NH
Clin Pharmacol Ther; 2011 Jun; 89(6):896-901. PubMed ID: 21562486
[TBL] [Abstract][Full Text] [Related]
36. An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions.
Gelincik A; Cavkaytar O; Kuyucu S
Curr Pharm Des; 2019; 25(36):3881-3901. PubMed ID: 31692425
[TBL] [Abstract][Full Text] [Related]
37. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
Halevy S
Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
[TBL] [Abstract][Full Text] [Related]
38. Skin signs of severe systemic medication reactions.
Treat JR
Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):193-7. PubMed ID: 22884025
[TBL] [Abstract][Full Text] [Related]
39. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
van Hattem S; Beerthuizen GI; Kardaun SH
Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of cutaneous adverse drug reactions.
Mockenhaupt M
Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
